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 Background: Thymus vulgaris essential oil (T) could be an alternative to classical 
antibiotics against bacterial biofilms, which show increased tolerance to antibiotics and 
host defence systems and contribute to the persistence of chronic bacterial infections. 
 Hypothesis: A nanovesicular formulation of T may chemically protect the structure 
and relative composition of its multiple components, potentially improving its 
antibacterial and antibiofilm activity. 
Study Design: We prepared and structurally characterized T in two types of 
nanovesicles: nanoliposomes (L80-T) made of Soybean phosphatidylcholine (SPC) and 
Polysorbate 80 (P80) [SPC:P80:T 1:0.75:0.3 w:w], and nanoarchaeosomes (A80-T) 
made of SPC, P80 and total polar archaeolipids (TPA) extracted from archaebacteria 
Halorubrum tebenquichense [SPC:TPA:P80:T 0.5:0.50.75:0.7 w:w]. We determined the 
macrophage cytotoxicity and the antibacterial activity against Staphylococcus aureus 
ATCC 25923 and four MRSA clinical strains. 
Results: L80-T (Z potential -4.1  0.6 mV,  115 nm,  22 mg/ml T) and A80-T (Z 
potential -6.6  1.5 mV,  130 nm,  42 mg/ml T) were colloidally and chemically 
stable, maintaining size, PDI, Z potential and T concentration for at least 90 days. While 
MIC90 of L80-T was > 4 mg/ml T, MIC90 of A80-T was 2 mg/ml T for all S. aureus 
strains. The antibiofilm formation activity was maximal for A80-T, while L80-T did not 
inhibit biofilm formation compared to untreated control. A80-T significantly decreased 
the biomass of preformed biofilms of S. aureus ATCC 25923 strain and of 3 of the 4 
clinical MRSA isolates at 4 mg/ml T. It was found that the viability of J774A.1 
macrophages was decreased significantly upon 24 h incubation with A80-T, L80-T and 
T emulsion at 0.4 mg/ml T. These results show that from 0.4 mg/ml T, a value lower 
than MIC90 and the one displaying antibiofilm activity, with independence of its 
formulation, T significantly decreased the macrophages viability.  
Conclusions: Overall, because of its lower MIC90 against planktonic bacteria, higher 
antibiofilm formation capacity and stability during storage, A80-T resulted better 
antibacterial agent than T emulsion and L80-T. These results open new avenues to 
explode the A80-T antimicrobial intracellular activity. 
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A80, nanoarchaeosomes; Abs, absorbance; ATCC, American Type Culture Collection; 
CFU, colony forming units; cryo-TEM, cryo-transmission electron microscopy; DLS, 
dynamic light scattering; DSC, differential scanning calorimetry; EO, essential oil; FBS, 
Fetal bovine serum; GC/MS, gas chromatography/mass spectrometry; GRAS, generally 
regarded as safe; INTI, National Institute of Industrial Technology; ISO, International 
Organization for Standardization; L80, nanoliposomes; MBC, minimum bactericidal 
concentration; MIC90, minimum inhibitory concentration 90; MRSA, methicillin-
resistant Staphylococcus aureus; OD, optical density; P80, Tween 80; PALS, phase 
analysis light scattering; PBS, phosphate buffer saline; PDI, polydispersity index; PL, 
phospholipids; SPC, Soybean phosphatidylcholine; T, Thymus vulgaris essential oil; 
TPA, Total polar archaeolipids; TRP, Thymus vulgaris essential oil submitted to reduced 
pressure; TSB, Tryptic soy broth; Tt, phase transition temperature 
 
Introduction  
As defined by the International Organization for Standardization (ISO), the term 
“essential oil” (EO) is reserved for a “product obtained from vegetable raw material, 
either by distillation with water or steam, or from the epicarp of citrus fruits by a 
mechanical process or by dry distillation” (ISO 9235, 1997), that is, by physical means 
only. Many individual components of EOs are generally regarded as safe (GRAS) by 
the FDA, a status that permitted the use of EOs as flavouring agents in food and as 
additives to cosmetics, perfumes, and cleaning products (Swamy et al., 2016). 
EOs constituents are lipophilic, highly volatile, secondary plant metabolites, reaching 
a mass below a molecular weight of 300, and have shown different antimicrobial 
properties against Gram-positive and negative bacteria and fungi (Swamy et al., 2016). 
Therefore, the antimicrobial activity of EO is associated to their lipophilic components, 
which may disrupt the lipid bilayer, increase cell permeability to end up in bacterial 
lysis. Those EOs with a high percentage of phenolic compounds possess the strongest 
antibacterial properties (Swamy et al., 2016). The constituents of EOs can act 
synergistically (phyto-synergic interactions) by different mechanisms which 
significantly reduce the possibility of occurrence of resistance. Interaction among 
compounds in the EO can involve the protection of an active substance from 
degradation by enzymes from the pathogen or the modification of transport across cell 














based on expulsion of antibiotic molecules ionic bomb-mediated (Bassolé and Juliani, 
2012). EOs thus may play a role in the search for new alternatives to classical 
antibiotics (Rai et al., 2017). 
The use of EO as antimicrobials however, is hampered by their low water solubility, 
chemical instability, photo lability, thermosensitivity and volatility. Nonetheless, such 
inconveniences may be reduced by loading EO into nanoparticulate material, a strategy 
aimed to protect the structure of carried drugs against physico-chemical and enzymatic 
attacks, and also to increase their shelf life, modify their pharmacokinetics, 
biodistribution and toxicological profile (Rai et al, 2017). One of the priority objectives 
of the WHO is finding new agents active against resistant bacteria, including 
methicillin-resistant Staphylococcus aureus (MRSA) (WHO, 2017). Once established, 
the S. aureus biofilms are refractory to antimicrobial and immune host response, 
constituting the etiological agent of recurrent infections. A nanovesicular formulation of 
EOs may chemically protect the structure and relative composition of its multiple 
components, potentially improving its antibacterial and antibiofilm activity, enabling its 
use beyond the food and cosmetic fields.  
In this work, Thymus vulgaris L. (Lamiaceae) EO (T) will be formulated into lipid 
nanovesicles prepared from polar archaeolipids extracted from the hyperhalophylic 
archaebacteria Halorubrum tebenquichense. In water media, polar archaeolipids form 
archaeosomes or nanoarchaeosomes, micrometer or submicrometer mean sized 
nanovesicles, respectively. Nanoarchaeosomes chemically differ from liposomes made 
of phospholipids (PL) extracted from bacteria and eukaryotes. Opposite to PL, the 
diphytanylglycerol diethers display sn2,3 stereoisomerism and fully saturated 
polyprenol chains are linked by ether instead of esters bond to the glycerol backbone. 
Different types of archaeolipids-containing soft colloidal nanostructures have repeatedly 
shown increased resistance to multiple insults such as mechanical stress, 
chemoenzymatic hydrolysis and oxidation, improving the protection to the carried drugs 
(Caimi et al, 2017 and 2019; Altube et al, 2016 and 2017). We hypothesize that T 
formulated in archaeolipid-containing nanovesicles would display improved structural 
protection during handling and storage, a fact that may help to increase its antimicrobial 
activity. A structural characterization of T loaded in nanoarchaeosomes will be provided 




















T was obtained from Euma, Buenos Aires, Argentina (density of T was considered 
0,915 g/ml). Soybean phosphatidylcholine (SPC, purity >90%) was a gift from Lipoid, 
Ludwigshafen, Germany. Polysorbate 80 (P80), molybdenum oxide, ascorbic acid, 
Sephadex G-25, 6-dodecanoyl-N, N-dimethyl-2-naphthylamine (laurdan), vancomycin, 
3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and crystal 
violet were purchased from Sigma-Aldrich (St Louis, MO, USA). Roswell Park 
Memorial Institute (RPMI) 1640 medium was from Gibco (Buenos Aires, Argentina). 
Fetal bovine serum (FBS), antibiotic/antimycotic solution (penicillin 10,000 IU/ml, 
streptomycin sulphate 10 mg/mL, amphotericin B 25 µg/ml), glutamine, and 
trypsin/ethylenediaminetetraacetic acid were from PAA Laboratories GmbH (Pasching, 
Austria). Tryptic soy broth (TSB) and bacteriological agar were acquired from Britania, 
Buenos Aires, Argentina. The other reagents were of analytic grade from Anedra 
(Buenos Aires, Argentina), Research AG (Tigre, Buenos Aires, Argentina). 
 
Characterization of T by gas chromatography/mass spectrometry 
 
The composition of T, and of T submitted to reduce pressure at 25 °C for 30 min 
(TRP) was analysed by gas chromatography/mass spectrometry (GC/MS). The GC/MS 
analysis was carried out in the Chemistry Centre of the National Institute of Industrial 
Technology (INTI, Buenos Aires, Argentina) on a Shimadzu GC 2010 Plus gas 
chromatograph coupled to a Shimadzu QP2010 ultra selective mass detector. Injector 
temperature was 250 °C in split mode (split ratio 1:60). The GC column was HP-PONA 
(50 m x 0.32 mm x 0.25 μm). Helium was used as carrier gas with a constant flow of 
1.66 ml/min. The temperature of the column was kept at 50° C for 3 min and was then 
raised to 230 °C (8 °C/min). Identification of individual components was made by 
comparison of their retention times with those of analytical standards and by matching 
















Archaebacteria growth, extraction, and characterization of total polar archaeolipids 
 
Halorubrum tebenquichense archaea were grown using a 25 l home-made stainless-
steel bioreactor in basal medium supplemented with yeast extract and glucose at 37 °C 
(Gonzalez, et al, 2009). Total polar archaeolipids (TPA) were extracted from biomass 
using the Bligh and Dyer method modified for extreme halophiles (Gonzalez, et al, 
2009). The reproducibility of each TPA-extract composition was routinely screened by 
phosphate content (Böttcher et al, 1961), and electrospray-ionization mass spectrometry, 
as described in Higa et al., 2012.  
 
Preparation of T-containing nanovesicles 
 
T containing ordinary liposomes (made of SPC:P80, L80-T) and nanoarchaeosomes 
(made of SPC:TPA:P80, A80-T) were prepared by the thin-film hydration method. 
Briefly, SPC, TPA, P80 and T were dissolved in CH3OH:CHCl3 1:1 v:v and combined 
in different proportions (SPC:P80:T 1:0.5:0.3, 1:0.5:0.7, 1:0.75:0.3, 1:0.75:0.7 w:w; and 
SPC:TPA:P80:T 0.5:0.50.75:0.7 w:w) to obtain suspensions of 40 or 80 mg/ml of PL. 
Then solvents were evaporated under reduced pressure at 25 °C for 30 min. The film 
was then hydrated with 10 mM Tris-HCl buffer pH 7.4 with 0.9% w/v NaCl (Tris-HCl 
buffer). 
Nanovesicles with the highest concentration of T were extruded 10 times through a 
sandwich of 2 polycarbonate membranes of 200 and 100 nm pore size, using a 
Thermobarrel extruder (Northern Lipids, Vancouver, Canada). 
Empty nanovesicles (L80 and A80) were prepared by the same procedure without the 
addition of T. A freshly prepared 55 mg/ml TRP in Tris-HCl buffer with 1% w/v of P80 
emulsion was used as control (T emulsion). 
 
Characterization of T-nanovesicles 
 
Composition and quantification of T, quantification of PL, size and Z potential 
 
T composition upon loaded in nanovesicles was determined by GC/MS as described 
above, after complete disruption of one volume of nanovesicles in 3 volumes of acetone 














T was quantified by absorbance at 275 nm upon complete disruption of one volume 
of nanovesicles in 500 volumes of ethanol. The absorption of the sample was compared 
to a standard curve prepared with TRP diluted in ethanol. The standard curve was linear 
in the range 0.015 and 0.183 mg/ml, with correlation coefficient of 0.999.  
PL were quantified by the colorimetric phosphate assay of Böttcher et al, 1961. 
Size (Z-average), polydispersity index (PDI) and zeta potential of nanovesicles were 
determined by dynamic light scattering (DLS) and phase analysis light scattering 
(PALS), respectively, using a nanoZsizer device (Malvern Instruments, Malvern, UK). 
Samples were diluted 1:20 in Tris-HCl buffer for size and Z potential measurements. 
 
Size exclusion chromatography  
 
Size exclusion chromatography was performed on Sephadex G-25, using the 
minicolumn centrifugation technique. Briefly, 150 μl aliquots of T-nanovesicles and T 
emulsion were seed on 3 ml syringe filled with Sephadex G-25 and centrifuged for 3 
min at 700 g. Five fractions were obtained after elution with 150 μl of Tris-HCl buffer. 
The elution profile was determined by quantifying each fraction T and PL as described 
above.  
 
Laurdan generalized polarization (GP) and fluorescence anisotropy (FA) 
 
The order and fluidity of the nanovesicles bilayer were determined by GP and FA of 
laurdan, respectively, according to (Altube et al, 2017). Briefly, void nanovesicles or T-
nanovesicles were labelled with laurdan by mixing 10 μl of 120 mM laurdan in 
methanol with a sufficient volume of nanovesicles to render a 1:20 mol:mol laurdan:PL 
ratio. Nanovesicles composed of SPC:TPA 1:1 w:w (A) or SPC only (L), prepared as 
described above, were used as control. The measurements were carried out in LS 55 
spectrofluorometer, PerkinElmer. 
GP was calculated using the following equation: GP = (I440 - I490)/(I440 + I490) where 
I440 and I490 are the fluorescence intensities at λem = 440 nm and λem = 490 nm, 
respectively, obtained from the spectra between 400 and 600 nm at λex = 364 nm (Slitex: 
5.0 nm and Slitem: 5.0 nm. Scan speed: 100 nm/min) 
FA was calculated using the spectrofluorometer software according to the following 














λem = 440 nm with λex = 364 nm and excitation polarizer oriented at 0 and at 90°, 
respectively. The correction factor G was obtained from the ratio of the emission 
intensity at 0 and 90° with the excitation polarizer oriented at 90 ° (after the subtraction 
of scattered light).  
 
Thermal analysis  
 
Phase transition temperature (Tt) and associated change of enthalpy (ΔH) of A80, 
L80, A80-T and L80-T were determined by differential scanning calorimetry (DSC), 
from −80 to 50 °C at 5 °C/min rate, in a Mettler Toledo DSC 30. A and L nanovesicles 




Morphology of A80 and A80-T was conducted by cryo-transmission electron 
microscopy (cryo-TEM). Samples were prepared in a controlled environment 
vitrification system Vitrobot Mark IV (Thermo Fischer Scientific, MA, USA) with 
controlled temperature (22 °C) and humidity (100%). Images were acquired on a 
TALOS F200C (Thermo Fischer Scientific, MA, USA) instrument, operating at 200 kV 
using a CMOS camera Ceta 16M 4k x 4k pixels (Thermo Fischer Scientific, MA, USA). 
Images were not processed after acquisition. Sample preparation and data acquisition 
were performed at the Electron Microscopy Laboratory (LME)/Brazilian 
Nanotechnology National Laboratory (LNNano). 
 
Stability upon storage 
 
The colloidal stability of A80-T, L80-T and T emulsion was determined after 90 days 
storage at 4 ºC. T quantification, nanovesicles size, PDI and Z potential before and after 




Immortalized murine macrophages J774A.1 (ATCC® TIB-67™) were supplied by 














Buenos Aires, Argentina. J774A.1 were routinely cultured in RPMI supplemented with 
10% FBS, 1% antibiotic-antimycotic and 2 mM glutamine at 37 °C in 5% CO2 and 95% 
humidity. 
Cell viability upon treatment with A80, A80-T, L80, L80-T and T emulsion was 
measured by MTT assay. Briefly, J774A.1 cells were seeded in 96-well plates at a 
density of 5 × 10
4
 per well and grown for 24 h. Then, cells were incubated with 100 µl 
of different concentration of formulations diluted in fresh medium with 5% FCS. The 
concentrations assayed were 0.1, 0.4 and 2.0 mg/ml of T for A80-T, L80-T and T 
emulsion. The concentrations of empty nanovesicles were 0.2, 0.5 and 2.6 and 0.2, 1.0 
and 5.0 mg/ml of PL for A80 and L80, respectively. After 24 h of incubation, cells were 
washed with phosphate buffer saline (PBS) and 100 μl of 5 mg/ml MTT solution was 
added to each well. After 3 h of incubation, the MTT solution was removed, the 
insoluble formazan crystals were dissolved in dimethyl sulfoxide, and absorbance was 
measured at 570 nm in a microplate reader (Cytation 5 BioTeck, Winooski, VT, USA). 
The cell viability was expressed as a percentage of the cells grown in medium. 
 
Antibacterial activity 
Bacterial strains and growth conditions 
 
The reference Staphylococcus aureus American Type Culture Collection (ATCC) 
25923 strain and four clinical methicillin-resistant S. aureus (MRSA) isolates (Cordobes 
clone, DOS90, DOS61 and DOS59), obtained and characterized by the Department of 
Microbiology, Parasitology and Immunology, Faculty of Medicine, University of 
Buenos Aires as described in Lattar et al, 2012, were used in this study. 
Bacteria were stored in TSB with 20% glycerol at −80 °C until use. All cultures were 
grown in TSB supplemented with 0.25% w/v glucose (TSB glucose) at 37 °C with 
shaking at 200 rpm overnight before testing. 
 
Growth of planktonic S. aureus, determination of MIC90 and MBC 
 
The growth of S. aureus after 24 h of incubation with T emulsion and T-nanovesicles 
was determined by optical density (OD) at 595 nm. Briefly, two fold dilutions of 
samples were prepared in TSB glucose, and 80 μl were added to wells in 96-well plate. 
















colony forming units (CFU)/ml and 20 μl of bacterial inoculum was added to each well. 
Immediately and 24 h after incubation at 37 °C, OD was measured at 595 nm in 
Multiskan EX plate reader (Thermo Fisher, MA, USA). Inoculum placed in TSB 
glucose medium was used as control without treatment and vancomycin was used as 
standard positive control. The percentage of bacterial growth was calculated respect the 
growth of control without treatment as follows: % growth = (OD24sample - 
OD0sample)/(OD24control- OD0control) * 100; where OD0sample and OD24sample are OD at 0 h 
and after 24 h incubation of S. aureus with samples, respectively; OD0control and 
OD24control are OD at 0 h and after 24 h of control, respectively. Each sample was 
assayed in triplicate and in two independent experiments.  
The minimum inhibitory concentration 90 (MIC90) was defined as the lowest 
concentration of samples that inhibits 90% growth respect to the control in TSB 
glucose. MIC90 was determined by growth results as the minimum concentration in 
which growth was ≤ 10%. 
Minimum bactericidal concentration (MBC) was determined by plating 10 μl from 
each well with growth ≤ 10% on TSB agar plates. After 24 h incubation, the MBC was 
regarded as the lowest concentration where no colonies were observed on the agar 
plates.  
 
Effect on biofilm formation 
 
Inhibition of biofilm formation was determined according to Mishra and Wang 
(2017). Supernatants of the microplate used for growth experiment were removed and 
the biomass of biofilm was determined by staining with crystal violet. Briefly, after two 
washes with sterile PBS, the 96-well plate was dried at 37 °C. The biofilm was fixed 
with methanol for 15 min. Then, methanol was removed, and the plate was allowed to 
dry again at 37 °C. Then 1% w/v crystal violet was added and after 20 min, two washes 
were carried out with distilled water and the plate was allowed to dry for 30 min at 37 
°C. Subsequently, stains were solubilized with 30% v/v acetic acid and absorbance of 
crystal violet at 595 nm (AbsCV) was measured. AbsCV was relativized to the final 
culture density (OD24h - OD0h) calculated before staining with crystal violet. 
 















Firstly, S. aureus biofilms were prepared. Briefly, 200 μl of bacterial inoculum, 
prepared as described above, was incubated at 37 °C in 96-well plates. After 24 h, the 
supernatants were removed, and biofilm washed with sterile physiological solution. T-
nanovesicles, T emulsion, empty nanovesicles and vancomycin were diluted in TSB 
glucose to obtain a final concentration of 4 mg/ml T, 5 mg/ml PL for A80, 10 mg/ml PL 
for L80 and 32 µg/ml vancomycin, respectively. Aliquots of 100 μl were added to 
biofilms and incubated for other 24 h at 37 °C. As a control without treatment, 100 μl of 
TSB glucose medium was added to S. aureus biofilm. After incubation, the supernatants 
were removed, biofilm was stained with crystal violet and AbsCV was determined as 
described above.  
The % of biofilm disruption was calculated as 100 – (AbsCV/AbsCVcontrol * 100) 
where AbsCV refers to absorbance of crystal violet after incubation of the biofilm with 
sample and AbsCVcontrol refers to the average of absorbance of control without treatment. 




Statistical analyses were performed by independent two-way analysis of variance 
(ANOVA) followed by Dunnet’s multiple comparisons test or one-way ANOVA 
followed by Tukey’s multiple comparisons test, using Prisma 4.0 Software (Graph Pad, 
San Diego, CA, USA). p-value less than 0.05 was considered statistically significant. *p 




Characterization of T by GC/MS 
 
The chemical composition of an EO can significantly vary according to several 
factors: the plant organ from which it is extracted, time of cultivation and harvest, 
climatic conditions of place of cultivation, and extraction method, among others 
(Angioni et al, 2006). Here the compositions of T and TRP as determined by GC/MS are 
shown in Table 1. The major components of T were thymol (30.2%), p-cymene 














the percentual composition of TRP compared to T, slightly increasing the thymol 
(35.4%) relative content.  
 
Structural features of T-nanovesicles  
 
Initial attempts to prepare nanovesicles made of lipid and T only failed, since the 
resultant lipid films could not be suspended upon buffer addition, even at different 
initial (T:lipid) ratios [data not shown]. Stable homogeneous suspensions were achieved 
however, only with ternary mixtures of lipid, T and P80. The PL:P80 ratio remained 
above 1:2.75 mol:mol (1:4 w:w); below which the P80 saturates the bilayer, solubilizing 
the PL and generating mixed micelles (Simões et al., 2005). It was observed also that 
regardless of the initial composition, only highly lipid concentrated T-nanovesicles [80 
and not 40 mg/ml PL] remained colloidally stable in time. Remarkably, the suspension 
stability depended on the initial (T:lipid) ratios and lipid composition. Aqueous 
suspension of bilayers made of SPC:P80:T 1:0.75:0.3 w:w (L80-T) was homogeneous 
(Fig. 1A) but bilayers made with double quantity of T (SPC:P80:T 1:0.75:0.7 w:w) 
rapidly formed two phases (Fig. 1B). However, by replacing half of SPC by TPA 
(SPC:TPA:P80:T 0.5:0.5:0.75:0.7 w:w, A80-T) the resulting homogeneous suspension 
remained stable in time (Fig. 1C). The theoretical concentration of L80-T and A80-T 
were 27.5 and 55 mg/ml T, with theoretical ratios of T/PL 27.5/80 [0.34] and 55/80 
[0.68], respectively. 
The structural features of T nanovesicles are detailed in Table 2. Remarkably, L80-T 
and A80-T at 55 - 58 mg/ml PL solubilized 22.0 ± 0.6 mg/ml and 41.6 ± 14.6 mg/ml T 
respectively, meaning loses in the order of 20-30% PL mass during nanovesicles 
extrusion. 
Polysorbate 80 molecule is a multi-headed structure, with four extended hydrophilic 
moieties, one of which has a tagged alkyl chain, that constitutes micelles of around 60 
molecules, displaying a radius of gyration of 26.2 Å and a physical radius, determined 
from both the radius of gyration and atomic density, of about 35 Å (Amani et al, 2011). 
T emulsion (TRP in Tris-HCl buffer with 1% w/v P80) showed a majoritarian population 
of (96%) 392 ± 33 nm and another (4%) of 4944 ± 320 nm hydrodynamic size, 















Potential changes in T composition upon loaded in nanovesicles were also surveyed. 
It was found that thymol was significantly increased at expenses of decreasing more 
volatile components (54.1% in A80-T and 52.5% L80-T) [data not shown]. This would 
signify that the effects of reduced pressure differed according to the chemical 
environment of T paradoxically, within nanovesicles the changes in relative 
composition were higher than in the oil form. 
 Fig. 2A showed that upon eluted by Sephadex-G25 size exclusion chromatography, 
the T emulsion microdroplets were collected in the first fraction [void volume]. The 
A80-T and L80-T elution profiles of T and PL were coincident (Fig. 2B and C), 
suggesting that T remained associated to nanovesicles during elution, indicating 
colloidal stability in front to dilution.  
The GP and FA of laurdan on the other hand, showed that the presence of P80 
profoundly modified the structure of L bilayers, that became more disordered and fluid. 
Opposing, P80 turned the A bilayers more ordered, while their fluidity was unaffected 
(Fig. 3A and B). The hydrophilic/lipophilic balance of P80 is 15, and acts as an o/w 
emulsifier, with relatively low tendency to interact with the lipid environment (El 
Maghraby et al, 2004). T could only be retained in nanovesicles bilayers when P80 was 
added, and T had an almost negligible effect on bilayer order and fluidity. Such apparent 
higher affinity of T by P80 suggests that probably T partitioned in P80 moieties present 
in nanovesicles bilayers, instead of in PL.  
The effect of P80 and T on the thermotropic behaviour of A and L bilayers was 
determined by DSC. The Tt of the lipid bilayer of A was -24.94 °C, with a ΔH of 84.4 
J/g PL (Fig. 4 and Table 3). While the presence of P80 induced a significant decrease of 
ΔH to 0.8 J/g, the Tt remained almost invariant at - 23.79 °C, the addition of T in A80-
T, induce a small peak at -51.06 °C.  
The Tt of the lipid bilayer of L was -25.14 °C with a ΔH of 81.4 J/g of PL. As 
previously determined in Perez et al, 2016 for SPC:P80 1:0.5 w:w, the phase transition 
of the SPC:P80 1:0.75 w:w was eliminated.  
Cryo-TEM images of A80 and A80-T showed spherical vesicles (Fig. 5 A and B), 
and no aggregates or micelles were observed. Some small nanovesicles were observed 
within larger vesicles. 
 















T emulsion resulted highly unstable; upon 24 h at 4 °C, 2 phases were formed. In 
contrast, L80-T and A80-T were colloidally and chemically stable, maintaining size, 




The J774A.1 macrophages viability was determined upon 24 h of incubation with 
A80, A80-T, L80, L80-T and T emulsion. It was found that the cell viability was 
decreased as the PL concentration of A80 increased (Fig. 7). The same trend was 
observed for A80-T, excepting that the presence of T in nanovesicle bilayer caused a 
more pronounced decrease in cell viability close to 90% at 0.4 mg/ml T. L80 had no 
deleterious effect on cell viability in the tested range, but 0.4 mg/ml T of L80-T 
decreased cell viability close to 70%. Finally, 0.4 mg/ml T emulsion decreased cell 
viability close to 100%. Taken together, these results show that from 0.4 mg/ml T a 
significantly decreased of macrophages viability was produced with independence of 
the formulation.  
 
Antibacterial activity (MIC90 and MBC) on planktonic S. aureus 
 
As expected, the standard antibiotic vancomycin decreased the growth of all S. 
aureus strains. Empty nanovesicles on the other hand, had no effect on the growth of S. 
aureus (Fig. 8 A), but T- nanovesicles and T emulsion decreased the growth of all S. 
aureus strains (Fig. 8 B-F). (Fig. 1S).  
Specifically, MIC90 of vancomycin was between 4-8 µg/ml and resulted comparable 
to MIC90 of L80-T and T emulsion, that was > 4 mg/ml. Notably, the MIC90 of A80-T 
was 2 mg/ml on all S. aureus strains (Table 4).  
On the other hand, MBC was > 4 mg/ml T for T-nanovesicles and T emulsion. 
However, a slight decrease in the number of CFU/ml was observed in all strains after 
incubation with 4 mg/ml A80-T. These results suggest that A80-T would be the most 
effective antiplanktonic agent. MBC of vancomycin was 16 µg/ml against ATCC 25923 
and DOS61 strains, 32 µg/ml for Cordobes clone, and > 32 µg/ml for DOS90 and 
DOS59 strains. 
 















We found that L80-T did not inhibit the biofilm formation, but T emulsion at 2 
mg/ml significantly inhibited biofilm formation of Cordobes clone and DOS90 strains 
and at 4 mg/ml inhibited ATCC 25923, DOS61 and DOS59 (Fig. 9). Remarkably 
however, A80-T at only 0.5 mg/ml significantly inhibited ATCC25923, DOS90 and 
DOS61 strains biofilm formation, whereas 1 mg/ml and 2 mg/ml were required to 
inhibit the Cordobes clone and DOS59 biofilms, respectively. Overall, the anti-biofilm 
formation activity was maximal for A80-T, at values lower than or equal to MIC90 and 
lower than MBC. This could be ascribed to its lower size and higher structural stability 
compared to the T emulsion and or to the T/PL ratio of A80-T two folds higher than that 
of L80-T. Impairing the biofilm formation may facilitate the further destruction of 
planktonic bacteria that would be unprotected.  
Remarkably, Vancomycin did not significantly inhibit the biofilm formation at any 
concentration assayed (Fig. 2S). 
Disruption of preformed biofilm 
 
Biofilms of different strains of S. aureus were prepared and incubated with empty 
nanovesicles, T-nanovesicles, T emulsion and vancomycin (Fig. 10). 
Empty nanovesicles and L80-T did not modify the biofilms biomass compared to 
untreated control. T emulsion and A80-T significantly decreased the biomass of the 
biofilms of S. aureus ATCC 25923 strain and of 3 of the 4 clinical MRSA isolates. The 
only strain refractory to biofilm disruption was the Cordobes clone. The disruption of 
preformed biofilm was thus strain dependent, probably arising from structural features 
hampering or facilitating the access of particulate material to bacterial targets.  
Vancomycin, despite of tested at concentration 4 and 8  folds higher than MIC90, did 




EOs are widely used as natural preserving agents to control lipid oxidation and 
microorganisms induced deterioration in food. In the last 5 years, the rise of 
nanotechnology on the food, livestock feed and pharmaceutics fields aroused a growing 
interest on loading techniques and performance of EO or isolated components in 














In this work, a colloidally stable formulation of T in nanovesicles was developed and 
its antiplanktonic bacterial and antibiofilm activities were determined. To the best of our 
knowledge, this is the first report of the loading of the essential oil T (and not the 
isolated thymol) in nanoparticles aimed for therapeutic use. Gortzi et al., 2006 for 
instance, loaded distinct species of Thymus gender EOs in multilamellar vesicles made 
of phosphatidylcholine:cholesterol:phosphatidylglycerol:Thymus spp EO 5:1:0.5:0.8 
w:w prepared by the hydration of the thin lipid film. The formulations however, lacked 
structural characterization and the final EO concentration was not determined. More 
recently, T or T/K proteinase were loaded in lipid vesicles of SPC:cholesterol:T 
1:0.2:0.25 w:w to be used in food industry aiming to decrease the E. coli O157:H7 
biofilms on the surface of vegetables (Cui et al., 2016). Here the nanovesicles were 
prepared by the hydration of thin film method, a technique involving solvent 
evaporation at reduced pressure. Though because of its simplicity the method is 
popularly used, the reduced pressure may affect the EO composition. Because of that, 
firstly the T composition was checked by GC/MS before and after submitted to reduce 
pressure or loading it in vesicles. It was found that the reduced pressure did not 
significantly modify the percentage of majoritarian components p-cymene, α-terpineol 
and linalool did not change while thymol was slightly concentrated. Regarding to the 
interaction between PL and EO components, studies by nuclear proton magnetic 
resonance spectroscopy (H-NMR) indicate that thymol and other phenols accommodate 
between the choline and glycerol backbone, close to the polar head of 
phosphatidylcholine and the first atoms of the acyl chains. The more lipophilic 
compounds prefer a deeper bilayer insertion to finally diminish the mobility of the 
hydrocarbon chains (Reiner et al., 2013a). Fluorescence anisotropy studies have also 
shown that phenols decrease the bilayers microviscosity (Reiner et al., 2013b). 
Discrepancies on the effect of EO on order and fluidity of PL bilayers are explained by 
the fact that our findings regard to the interaction of a complex molecular mixture 
conforming the T, instead of isolated molecules. In our experience, the thin film method 
did not allow partitioning EO into lipid films to render colloidally stable formulations. 
To overcome such issue and avoid the generation of two phases, a surfactant was 
included to the lipid bilayers. The non-ionic P80 surfactant is a widely used solubilizing 
agent and stabilizing/emulsifier in pharmaceutic formulations. P80 inserts in the lipid 
bilayer with its oleate (lipophilic) residua aligned in parallel with the acyl chains while 














(El Maghraby et al., 2004). The increased volume of the headgroup would facilitate the 
fitting of the thymol in that area. Our mixed bilayer made of PL and P80 enabled to 
achieve aqueous dispersions of 22 mg/ml T and by replacing half SPC by archaeolipids, 
it was raised to 41 mg/ml T, nearly 2.5 folds higher than T emulsion (that dropped from 
55 to 16 mg/ml T upon 24 h) or 24 folds higher than the 1.7 mg/ml T of formulations 
developed by Cui. Remarkably, the presence of archaeolipids not only provided higher 
T/PL ratios but of a longer structural stability during storage.  
Skin bacterial infections are highly common and involve mostly Gram-positive 
bacteria; those caused by MRSA comprise nearly 50% of the isolates from S. aureus 
(Cardona and Wilson, 2015). The reason why leg venous, pressure, and diabetic foot 
ulcers become chronic is the formation of biofilms, responsible for permanent 
inflammation in the wound and lengthy healing (Percival et al., 2012). Pathogenicity of 
antibiotic resistant S. aureus infections acquired in hospitals and community rely in part 
on the biofilm formation. Biofilms are structured consortium of bacteria embedded in a 
self-produced polymer matrix consisting of polysaccharide, protein and DNA (Percival 
et al., 2012). S. aureus biofilms are present in multiple infections associated to medical 
dispositive, osteomyelitis, chronic skin wounds, periodontitis, chronic sinusitis, 
endocarditis and eye infections (Archer et al, 2011). Treatments against early 
established biofilms render the best results (Høiby et al, 2015). However, the biofilms 
capacity to persist long periods without being detected or eradicated by the host immune 
system makes the diagnosis difficult. The only current effective methods are physical 
removal of the infection source; the antibiotic therapy is poorly effective to defeat the 
infection (Høiby et al, 2015). Finally, the phenotype of bacteria in biofilms is different 
from that of planktonic; but even the sensitive to methicillin strains may tolerate much 
higher concentrations of antibiotics than isogenic planktonic ones, which makes 
difficult to eradicate infections. Taken together, these reasons make the search for new 
anti-biofilm forming MRSA agents, of outmost importance.  
Although more research and clinical trials are needed, it has recently been proposed 
to replace conventional antibiotics with EOs (Swamy et al, 2016). There is also growing 
interest in the synergistic combination of conventional antibiotics with EOs to combat 
antibiotic resistance (Lahmar et al, 2017). 
The MIC and MBC of T against planktonic S. aureus recalled by other authors is 
highly variable, probably owed to the different sources and obtaining methods of T and 














(see Table 5). Such variability difficult accurate comparisons. Kavanaugh and Ribbeck, 
2012 for instance, determined a higher efficacy of T compared to oxacillin and 
methicillin antibiotics, at a minimum concentration for biofilm eradication of 1.7% v/v 
T (7 mg/ml T), by measuring CFU/ml in biofilms from a clinical MRSA strain. Al-
Shuneigat et al., 2014 on the other hand, determined that the minimum concentration 
that caused a 30% decrease in AbsCV of MRSA and methicillin sensitive S. aureus 
clinical strain biofilm was 0.25% v/v T (1.1 mg/ml T). There are few reports combining 
accurate analytical structural description of the carrier nanoparticles for T, together with 
its antimicrobial activity. One of them is Gortzi et al, 2006 that loaded Thymus spp (T. 
longicaulis and T. ocheus) EO in nanovesicles, to observe by disk diffusion, higher 
activity of EO in nanovesicles than free EO against planktonic S. aureus. 
Our results suggest that A80-T may be used to magnify the antimicrobial activity of 
T against planktonic and in MRSA biofilm. We found that while L80-T at 4 mg/ml T 
was inactive, T emulsion and A80-T significantly decreased the biofilm biomass of a S. 
aureus reference strain and 3 MRSA strains. Nonetheless, despite of its A80-T 
comparable disrupting biofilm activity, the colloidal stability of T emulsion was poor, 
collapsing 24 h after prepared. Finally, the idea of employing A80-T as antimicrobial 
agent deserves to be carefully considered in the light of the pronounced cytotoxicity of 
T emulsion and T-nanovesicles on J774A.1 macrophages, at concentrations lower than 
the MIC. Oliveira et al, 2017 had already reported a reduction of 20 to 40% the viability 
of RAW 264.7 macrophages upon 5 min incubation with a Thymus vulgaris glycolic 
extract at concentrations below those causing a significant diminution of CFU/ml in S. 
aureus ATCC 6538 biofilms. Macrophages act as first line of defence against microbes 
and are critical to amplify and orchestrate the activation/recruitment of immune cells. S. 
aureus is capable of surviving and persisting within different types of host cells, 
including macrophages and keratinocytes (Jakab and Green, 1976; Kintarak et al, 2004). 
In such cases, the pronounced toxicity of A80-T on macrophages may help to eradicate 




Overall, because of its lower MIC90 against planktonic bacteria, higher antibiofilm 
formation capacity and stability during storage, A80-T resulted better antibacterial agent 
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 Fig. 1. Aqueous suspension of bilayers made of (A) SPC:T80:T 1:0.75:0.3 w:w, (B) 
SPC:T80:T 1:0.75:0.7 w:w and (C) SPC:TPA:T80:T 0.5:0.5:0.75:0.7 w:w. 
 Fig. 2. Size exclusion chromatography elution profile of (A) T emulsion, (B) L80-T and 
(C) A80-T. Values are expressed as mean ± SD (n = 3). 
 Fig. 3. (A) Laurdan generalized polarization (GP) and (B) fluorescence anisotropy (FA) 
in nanovesicles. Values are expressed as mean ± SD (n = 3). 
 Fig. 4. Thermal analysis by DSC of A, A80, A80-T, L, L80 and L80-T. 
 Fig. 5. Cryo-TEM images of (A) A80 and (B) A80-T.  
 Fig. 6. Colloidal and chemical stability of A80-T and L80-T upon storage, (A) Z-














potential (Columns show % of T and dots show Z potential). Values are expressed as 
mean ± SD (n = 3). 
 Fig. 7. Viability of J774A.1 cells upon 24 h incubation with A80, A80-T, L80, L80-T 
and T emulsion evaluated by MTT assay. Values are express as mean ± SD (n=3). 
 Fig. 8. Bacterial growth of S. aureus strains (A) ATCC 25923, (B) Cordobes clone, (C) 
DOS90, (D) DOS61 and (E) DOS59, in the presence of different concentrations of T 
emulsion, A80-T and L80-T. (F) Bacterial growth of S. aureus strains incubated with 
A80 (5 mg/ml PL) and L80 (10 mg/ml PL). Values are expressed as mean ± SD (n = 2). 
 Fig. 9. Inhibition of biofilm formation by T emulsion, A80-T and L80-T on S. aureus 
stains (A) ATCC 25923, (B) Cordobes clone, (C) DOS90, (D) DOS61 and (E) DOS59. 
Values are expressed as mean ± SD (n = 2).  
 Fig. 10. % of biofilm disruption of S. aureus strains (A) ATCC 25923, (B) Cordobes 
clone, (C) DOS90, (D) DOS61 and (E) DOS59, after incubation with 5 mg/ml of PL as 
A80, 10 mg/ml of PL as L80, 4 mg/ml of T as T emulsion, A80-T and L80-T and 32 
µg/ml of vancomycin. Values are expressed as mean ± SD (n = 2). 
 Fig. 1S. Bacterial growth of S. aureus strains (A) ATCC 25923, (B) Cordobes clone, 
(C) DOS90, (D) DOS61 and (E) DOS59 incubated with different concentrations of 
vancomycin. Values are expressed as mean ± SD (n = 2). 
 Fig. 2S. Inhibition of biofilm formation by vancomycin on S. aureus stains (A) ATCC 
25923, (B) Cordobes clone, (C) DOS90, (D) DOS61 and (E) DOS59. Values are 
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Table 1. Chemical composition of T and TRP. 
Retention time 
(min) 
Component T %  TRP % 
7.815 α-Pinene 3.68 1.82 
8.294 Camphene 1.30 0.67 
9.244 β-Pinene 0.46 0.19 
9.783 Myrcene 1.75 0.98 
10.901 p-Cymene 22.91 21.02 
11.046 Limonene 0.11 0.07 
11.125 1.8-Cineol 2.38 1.81 
13.559 Linalool 10.21 10.46 
14.742 1-Terpineol 1.32 1.29 
15.080 β-Terpineol 3.22 3.21 
16.667 α-Terpineol 12.42 13.29 
16.903 γ-Terpineol 5.01 5.19 
20.051 Thymol 30.20 35.40 
24.000 β-Caryophyillene 2.05 2.13 
 Total 97.02 97.53 
 
 
Table 2. Composition and structural characteristics of nanovesicles. Values given are 

























41.6 ± 14.6 129.2 ± 23.0 0.21 ± 0.06 -6.6 ± 1.5 
 
Table 3. Thermotropic parameters of A, A80, A80-T, L, L80 and L80-T. 
Formulation Tt (°C) ∆H (J/g PL) 
A -24.94 84.4 
A80 -23.79 0.8 
A80-T -51.06 6 














L80 - - 
L80-T - - 
 
Table 4. MIC90 of A80, L80, T emulsion, A80-T, L80-T and vancomycin against S. 
aureus. n=2 
Strain of S. 
aureus 
MIC90 (mg/ml PL) MIC90 (mg/ml T) MIC90  
vancomycin 
(µg/ml) 
A80 L80 T emulsion A80-T L80-T 
ATCC 
25923 
>5 >10 >4 2 >4 8 
Cordobes 
clone 
>5 >10 >4 2 >4 8 
DOS90 >5 >10 >4 2 >4 4 
DOS61 >5 >10 >4 2 >4 8 
DOS59 >5 >10 >4 2 >4 8 
 
 
Table 5. Examples of antibacterial activity of T (density of T was considered 0,915 g/ml 




S. aureus strain MIC 
Tohidpour et al, 
2010 
T diluted in 
Muller Hinton 
with 0.5% v/v 
of Tween 20 






al, 2014  











T diluted in 
Mueller Hinton 
broth with 
0.1% v/v of 
T80 
MRSA clinical 
strain 
7 mg/ml 
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